European agency rejects Serostim
BY Advocate.com Editors
May 01 2003 12:00 AM ET
The European Medicines Evaluations Agency on Monday announced that its scientific committee has rejected an application by Serono to market its anti-wasting drug Serostim to AIDS patients in Europe. The drug is approved for the treatment of AIDS-related wasting in the United States. In a statement, the agency said there was concern about the long-term safety of the medication and that long-term efficacy data also was lacking. Serostim is a recombinant human growth hormone that has been shown to increase muscle mass in those taking the medication.
- Time to #BoycottIndiana? Celebs Blow Up Social Media
- 7 Immediate Examples of Backlash to Indiana's 'Religious Freedom'
- Trixie Mattel on Drag Race Elimination: 'It Was Rude'
- WATCH: To Rand Paul, Marriage Equality Signals 'Moral Crisis'
- Michigan Woman Sues Planet Fitness Over Trans-Inclusive Locker Room
- After Indiana, 23 More States Could Pass Discrimination Bills